Español
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI Dictionary of Cancer Terms


rhIL-11   

  A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. rhIL-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and recombinant human interleukin-11.